Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Daperno

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Inflammatory Bowel Diseases|April 25, 2024
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's DiseaseReena Khanna, Brian G Feagan, Guangyong Zou, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Female reproductive health and inflammatory bowel disease: A practice-based review, Alessandro Armuzzi, Aurora Bortoli, et al.
Journal of Crohn'S & Colitis|January 30, 2014
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomyRita Monterubbianesi, Annalisa Aratari, Alessandro Armuzzi, et al.
Journal of Crohn'S & Colitis|August 13, 2014
Patient and physician views on the quality of care in inflammatory bowel disease: results from SOLUTION-1, a prospective IG-IBD studyAurora Bortoli, Marco Daperno, Anna Kohn, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 10, 2017
Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD studyMarco Daperno, Aurora Bortoli, Anna Kohn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2010
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel diseaseMario Cottone, Anna Kohn, Marco Daperno, et al.
Endoscopy|March 24, 2018
Development and validation of the SIMPLE endoscopic classification of diminutive and small colorectal polypsMarietta Iacucci, Cristina Trovato, Marco Daperno, et al.
Autoimmunity Reviews|April 29, 2026
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized careGiuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trialSilvio Danese, Severine Vermeire, Geert D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2023
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUSTLaurent Peyrin-Biroulet, Séverine Vermeire, Geert D'Haens, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Inflammatory Bowel Diseases|April 25, 2024
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's DiseaseReena Khanna, Brian G Feagan, Guangyong Zou, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Female reproductive health and inflammatory bowel disease: A practice-based review, Alessandro Armuzzi, Aurora Bortoli, et al.
Journal of Crohn'S & Colitis|January 30, 2014
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomyRita Monterubbianesi, Annalisa Aratari, Alessandro Armuzzi, et al.
Journal of Crohn'S & Colitis|August 13, 2014
Patient and physician views on the quality of care in inflammatory bowel disease: results from SOLUTION-1, a prospective IG-IBD studyAurora Bortoli, Marco Daperno, Anna Kohn, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 10, 2017
Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD studyMarco Daperno, Aurora Bortoli, Anna Kohn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2010
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel diseaseMario Cottone, Anna Kohn, Marco Daperno, et al.
Endoscopy|March 24, 2018
Development and validation of the SIMPLE endoscopic classification of diminutive and small colorectal polypsMarietta Iacucci, Cristina Trovato, Marco Daperno, et al.
Autoimmunity Reviews|April 29, 2026
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized careGiuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trialSilvio Danese, Severine Vermeire, Geert D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2023
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUSTLaurent Peyrin-Biroulet, Séverine Vermeire, Geert D'Haens, et al.
Pageof 10